Friday, April 5, 2019

Inscripta Adds $20M To Series C Funding

Boulder-based gene editing technology developer Inscripta has added another $20M in funding to its Series C round, the company said this week, bringing the round to a total of $105.5M

The story you have requested is only available to paid members of the Techrockies.com web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.